EATL is a dubious disease in the field of infectious respiratory digestive and endocrine disorders, clinical performance is complex and often involves multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have improved significantly. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of intestinal T-cell lymphoma EATL. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: Arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: One-stop services: Medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.